COMMUNIQUÉ RÉGLEMENTÉ
News
-
-
COMMUNIQUÉ RÉGLEMENTÉ
TINC publiceert een sterk tussentijds resultaat en ligt op schema om haar portefeuille te verdubbelen na de volledige investering van de opbrengst van de recente kapitaalverhoging
TINC verdubbelt portefeuille na sterke investeringen en kapitaalverhoging, met focus op infrastructuurbedrijven en rendement. Tussentijds resultaat toont groei en waarde-creatie voor aandeelhouders -
COMMUNIQUÉ RÉGLEMENTÉ
TINC publishes strong interim results and is well on track to double its investment portfolio with the proceeds of the recent rights issue fully invested
TINC doubles investment portfolio with strong interim results and strategic growth, distributing €0.59 per share to shareholders. Total cash receipts €46.4M -
COMMUNIQUÉ RÉGLEMENTÉ
TINC publishes strong interim results and is well on track to double its investment portfolio with the proceeds of the recent rights issue fully invested
TINC reports strong interim results, fully investing recent rights issue proceeds to double investment portfolio. Shareholders' equity grows to €615.3 million -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
Lobe Sciences Ltd. to participate in Clusterbusters 20th Annual U.S. Patient Conference to highlight psilocin treatment for cluster headaches and discuss funding success for further research and development
